Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hypertension
Biotech
Roche, Alnylam celebrate second ph. 2 win for blood pressure med
In further proof that Roche’s $310 million bet will pay off, the Big Pharma’s Alnylam-partnered hypertension drug has notched another win.
James Waldron
Mar 5, 2024 9:05am
Closed Loop dose-setting app boosts hypertension success: study
Feb 8, 2024 11:42am
Nanowear collects FDA OK for wearable AI blood pressure monitor
Jan 5, 2024 2:54pm
Medtronic claims long-sought FDA approval in renal denervation
Nov 20, 2023 10:21am
Idorsia lays off 300 staff after previewing cost cuts in July
Oct 24, 2023 10:30am
Roche's bet pays off as Alnylam hypertension med hits in phase 2
Sep 7, 2023 8:55am